Cargando…

The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth

BACKGROUND: Herpes simplex virus type 2 (HSV-2) is the leading cause of genital ulcer disease worldwide. The virus can be transmitted to neonates and there are scarce data regarding incidence of HSV-2 among women in pregnancy and after childbirth. The aim of this study is to measure the incidence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Munjoma, Marshall W, Kurewa, Edith N, Mapingure, Munyaradzi P, Mashavave, Grace V, Chirenje, Mike Z, Rusakaniko, Simbarashe, Hussain, Akhtar, Stray-Pedersen, Babill
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819995/
https://www.ncbi.nlm.nih.gov/pubmed/20064273
http://dx.doi.org/10.1186/1472-6874-10-2
_version_ 1782177331537772544
author Munjoma, Marshall W
Kurewa, Edith N
Mapingure, Munyaradzi P
Mashavave, Grace V
Chirenje, Mike Z
Rusakaniko, Simbarashe
Hussain, Akhtar
Stray-Pedersen, Babill
author_facet Munjoma, Marshall W
Kurewa, Edith N
Mapingure, Munyaradzi P
Mashavave, Grace V
Chirenje, Mike Z
Rusakaniko, Simbarashe
Hussain, Akhtar
Stray-Pedersen, Babill
author_sort Munjoma, Marshall W
collection PubMed
description BACKGROUND: Herpes simplex virus type 2 (HSV-2) is the leading cause of genital ulcer disease worldwide. The virus can be transmitted to neonates and there are scarce data regarding incidence of HSV-2 among women in pregnancy and after childbirth. The aim of this study is to measure the incidence and risk factors for HSV-2 infection in women followed for 9 months after childbirth. METHODS: Pregnant women were consecutively enrolled late in pregnancy and followed at six weeks, four and nine months after childbirth. Stored samples were tested for HSV-2 at baseline and again at nine months after childbirth and HSV-2 seropositive samples at nine months after childbirth (seroconverters) were tested retrospectively to identify the seroconversion point. RESULTS: One hundred and seventy-three (50.9%) of the 340 consecutively enrolled pregnant women were HSV-2 seronegative at baseline. HSV-2 incidence rate during the 10 months follow up was 9.7 (95% CI 5.4-14.4)/100 and 18.8 (95% CI 13.9-26.1)/100 person years at risk (PYAR) at four months and nine months after childbirth respectively. Analysis restricted to women reporting sexual activity yielded higher incidence rates. The prevalence of HSV-2 amongst the HIV-1 seropositive was 89.3%. Risk factors associated with HSV-2 seropositivity were having other sexual partners in past 12 months (Prevalence Risk Ratio (PRR) 1.8 (95% CI 1.4-2.4) and presence of Trichomonas vaginalis (PRR 1.7 95% CI 1.4-2.1). Polygamy (Incidence Rate Ratio (IRR) 4.4, 95% CI 1.9-10.6) and young age at sexual debut (IRR 3.6, 95% CI 1.6-8.3) were associated with primary HSV-2 infection during the 10 months follow up. CONCLUSIONS: Incidence of HSV-2 after childbirth is high and the period between late pregnancy and six weeks after childbirth needs to be targeted for prevention of primary HSV-2 infection to avert possible neonatal infections.
format Text
id pubmed-2819995
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28199952010-02-11 The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth Munjoma, Marshall W Kurewa, Edith N Mapingure, Munyaradzi P Mashavave, Grace V Chirenje, Mike Z Rusakaniko, Simbarashe Hussain, Akhtar Stray-Pedersen, Babill BMC Womens Health Research article BACKGROUND: Herpes simplex virus type 2 (HSV-2) is the leading cause of genital ulcer disease worldwide. The virus can be transmitted to neonates and there are scarce data regarding incidence of HSV-2 among women in pregnancy and after childbirth. The aim of this study is to measure the incidence and risk factors for HSV-2 infection in women followed for 9 months after childbirth. METHODS: Pregnant women were consecutively enrolled late in pregnancy and followed at six weeks, four and nine months after childbirth. Stored samples were tested for HSV-2 at baseline and again at nine months after childbirth and HSV-2 seropositive samples at nine months after childbirth (seroconverters) were tested retrospectively to identify the seroconversion point. RESULTS: One hundred and seventy-three (50.9%) of the 340 consecutively enrolled pregnant women were HSV-2 seronegative at baseline. HSV-2 incidence rate during the 10 months follow up was 9.7 (95% CI 5.4-14.4)/100 and 18.8 (95% CI 13.9-26.1)/100 person years at risk (PYAR) at four months and nine months after childbirth respectively. Analysis restricted to women reporting sexual activity yielded higher incidence rates. The prevalence of HSV-2 amongst the HIV-1 seropositive was 89.3%. Risk factors associated with HSV-2 seropositivity were having other sexual partners in past 12 months (Prevalence Risk Ratio (PRR) 1.8 (95% CI 1.4-2.4) and presence of Trichomonas vaginalis (PRR 1.7 95% CI 1.4-2.1). Polygamy (Incidence Rate Ratio (IRR) 4.4, 95% CI 1.9-10.6) and young age at sexual debut (IRR 3.6, 95% CI 1.6-8.3) were associated with primary HSV-2 infection during the 10 months follow up. CONCLUSIONS: Incidence of HSV-2 after childbirth is high and the period between late pregnancy and six weeks after childbirth needs to be targeted for prevention of primary HSV-2 infection to avert possible neonatal infections. BioMed Central 2010-01-12 /pmc/articles/PMC2819995/ /pubmed/20064273 http://dx.doi.org/10.1186/1472-6874-10-2 Text en Copyright ©2010 Munjoma et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Munjoma, Marshall W
Kurewa, Edith N
Mapingure, Munyaradzi P
Mashavave, Grace V
Chirenje, Mike Z
Rusakaniko, Simbarashe
Hussain, Akhtar
Stray-Pedersen, Babill
The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
title The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
title_full The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
title_fullStr The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
title_full_unstemmed The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
title_short The prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant Zimbabwean women followed up nine months after childbirth
title_sort prevalence, incidence and risk factors of herpes simplex virus type 2 infection among pregnant zimbabwean women followed up nine months after childbirth
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819995/
https://www.ncbi.nlm.nih.gov/pubmed/20064273
http://dx.doi.org/10.1186/1472-6874-10-2
work_keys_str_mv AT munjomamarshallw theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT kurewaedithn theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT mapinguremunyaradzip theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT mashavavegracev theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT chirenjemikez theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT rusakanikosimbarashe theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT hussainakhtar theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT straypedersenbabill theprevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT munjomamarshallw prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT kurewaedithn prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT mapinguremunyaradzip prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT mashavavegracev prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT chirenjemikez prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT rusakanikosimbarashe prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT hussainakhtar prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth
AT straypedersenbabill prevalenceincidenceandriskfactorsofherpessimplexvirustype2infectionamongpregnantzimbabweanwomenfollowedupninemonthsafterchildbirth